The Gene Box
PrivateLast Round
Accelerator
Apr 1, 2018
Company Overview
The Gene Box is a health-tech company that provides a multi-omic platform for precision health, integrating DNA, microbiome, and blood intelligence for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Gene Box Comparables
Compare The Gene Box with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SelfDecode | 81% | |
| 3X4 Genetics | 71% | |
| Molecular You | 65% |
The Gene Box Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 37% MoM.
- Jan 31, 2026
Monthly visitors grew 123% MoM, reaching 1K.
The Gene Box Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about The Gene Box's valuation, stock price, and market status.
Is The Gene Box a public or private company?
The Gene Box is a private company.
What is the current stock price of The Gene Box?
The Gene Box is a private company with no public stock price. No recent secondary market data is available.
How much is The Gene Box worth (valuation)?
Valuation information for The Gene Box is not publicly available.
Can I buy The Gene Box stock?
The Gene Box shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was The Gene Box's last funding round?
The Gene Box's most recent funding round was Accelerator on April 1, 2018.
Who are the main investors in The Gene Box?
Investor information for The Gene Box is not publicly disclosed.
Will The Gene Box IPO soon?
No public IPO plans have been announced for The Gene Box.
How can I track The Gene Box secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor The Gene Box's secondary market activity and sign up for updates.